Implementing tuberculosis entry screening for asylum seekers: The Groningen experience

European Respiratory Journal

Volumn 48, Issue 1, 2016, Pages 261-264

  Akkerman, Onno W ^a   De Lange, Wiel C M ^a   Schölvinck, Elisabeth H ^a   Wolters, Bert ^b   Aartsma, Yvonne ^b   Van Der Werf, Tjip S ^a   Van Hest, Rob ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Municipal Public Health Service Groningen   (Netherlands)

^c Regional Public Health Service Rotterdam Rijnmond   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOSCOPY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LETTER; LUNG TUBERCULOSIS; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; SPUTUM SMEAR; STRUCTURED QUESTIONNAIRE; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TOILET; TUBERCULIN TEST; ADULT; COMMUNICABLE DISEASE CONTROL; FEMALE; MALE; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PROCEDURES; REFUGEE; STATISTICS AND NUMERICAL DATA; TRANSMISSION; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, ORGANIZATIONAL; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); REFUGEES; TUBERCULOSIS;

EID: 84977104403     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00112-2016     Document Type: Letter

References (15)

1. Migliori GB, Zellweger JP, Abubakar I, et al. European union standards for tuberculosis care. Eur Respir J 2012; 39: 807-819.
2. Abubakar I, Story A, Lipman M, et al. Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population. Eur Respir J 2010; 35: 689-692.
3. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2015. Stockholm, European Centre for Disease Prevention and Control, 2015.
4. Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928-952.
5. Klinkenberg E, Manissero D, Semenza JC, et al. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J 2009; 34: 1180-1189.
6. Dara M, de Colombani P, Petrova-Benedict R, et al. The minimum package for cross-border TB control and care in the WHO European Region: a Wolfheze Consensus Statement. Eur Respir J 2012; 40: 1081-1090.
7. Harsted I, Jacobsen GW, Heldal E, et al. The role of entry screening in case finding of tuberculosis among asylum seekers in Norway. BMC Public Health 2010; 10: 670.
8. Schneeberger Geisler S, Helbling P, Zellweger JP, et al. Screening for tuberculosis in asylum seekers: comparison of chest radiography with an interview-based system. Int J Tuberc Lung Dis 2010; 14: 1388-1394.
9. De Vries G, van Rest J, Meijer W, et al. Low yield of screening asylum seekers from countries with a tuberculosis incidence of 50 per 100 000 population. Eur Respir J 2016; 47: 1870-1872.
10. Getahun H, Matteelli A, Abubakar I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563-1576.
11. Erkens CG, Slump E, Verhagen M, et al. Monitoring latent tuberculosis infection diagnosis and management in the Netherlands. Eur Respir J 2016; 47: 1492-1501.
12. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000; 161: 780-789.
13. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J 2005; 25: 1107-1116.
14. Mandalakas AM, Menzies D. Is screening immigrants for latent tuberculosis cost-effective? Lancet Infect Dis 2011; 11: 418-419.
15. Wingate LT, Coleman MS, de la Motte Hurst C, et al. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program. BMC Public Health 2015; 15: 1201.